Jose T Flores-Lopez, MD
Psychiatry · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 5
- 3 carriers
- Office
- 1
Offices
1 location · Bay Area Community Health · 106 clinicians in this group
Plans that list them
5 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Flores-Lopez’s office at (408) 729-9700 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
5 of 5 plans
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G50533 · Current
Licensed to practise in California · since 1983 · expires 2027-05-31 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$7,602
Medicare paid this office $7,602 for 13 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Psychiatric diagnostic evaluation with medical services | 12 | $4,676 | $134 |
Who their Medicare patients are
13 Original Medicare patients in 2024. Average age 45 · Also on Medicaid 100% · Health risk score 1.84. Above the middle of the specialty; the typical psychiatry clinician is at 1.35.
The office billed $35,441, Medicare allowed $9,833 and paid $7,602; for 68 services of 2 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 13 | 68 | 45 | 1.84 | $35,441 | $7,602 |
| 2023 | 26 | 68 | 47 | 0.92 | $23,736 | $6,389 |
| 2022 | 27 | 89 | 49 | 1.17 | $34,068 | $7,375 |
| 2018 | 85 | 259 | 52 | 1.36 | $102,750 | $16,965 |
| 2017 | 111 | 303 | 51 | 1.28 | $109,852 | $22,318 |
| 2013 | 14 | 56 | 41 | 0.76 | $12,180 | $2,427 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Psychiatric diagnostic evaluation with medical services | 15 | $3,614 | $139 |
| Return visit (30+ min) | 18 | $2,659 | $65 |
2022: 1 service
| Return visit (30+ min) | 22 | $6,058 | $77 |
2018: 2 services
| Long return visit (40+ min) | 72 | $12,847 | $74 |
| Return visit (30+ min) | 52 | $4,098 | $49 |
2017: 2 services
| Long return visit (40+ min) | 94 | $14,698 | $86 |
| Return visit (30+ min) | 78 | $7,521 | $59 |
2013: 1 service
| Return visit (30+ min) | 14 | $1,726 | $38 |
Medicaid work
$48,604 in 2024
Medicaid paid $48,604 for 361 billed services this clinician did in 2024, up to 29 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 145 | $38,568 |
| Return visit (30+ min) | 170 | $8,188 |
| Short return visit (20+ min) | 46 | $1,849 |
| 2024 | 361 | 3 | 29 | $48,604 |
| 2023 | 716 | 4 | 21 | $82,518 |
| 2022 | 788 | 3 | 21 | $73,448 |
| 2021 | 2,212 | 4 | 86 | $150,157 |
| 2020 | 1,935 | 5 | 74 | $95,963 |
| 2019 | 148 | 4 | 28 | $4,406 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 253 | $65,205 |
| Return visit (30+ min) | 378 | $15,266 |
| Long return visit (40+ min) | 33 | $1,896 |
| Short return visit (20+ min) | 52 | $152 |
2022
| Clinic visit/encounter, all-inclusive | 218 | $49,967 |
| Long return visit (40+ min) | 374 | $21,659 |
| Short return visit (20+ min) | 196 | $1,822 |
2021
| Clinic visit/encounter, all-inclusive | 862 | $143,752 |
| Short return visit (20+ min) | 736 | $4,203 |
| Return visit (30+ min) | 298 | $2,072 |
| Long return visit (40+ min) | 316 | $129 |
2020
| Clinic visit/encounter, all-inclusive | 768 | $88,719 |
| Return visit (30+ min) | 933 | $6,753 |
| Short return visit (20+ min) | 138 | $304 |
| Long return visit (40+ min) | 83 | $187 |
| New patient visit (45+ min) | 13 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 42 | $4,406 |
| New patient visit (45+ min) | 12 | $0 |
| New patient visit (60+ min) | 19 | $0 |
| Return visit (30+ min) | 75 | $0 |
Drugs they prescribed that Part D paid
$143,891
Pharmacies billed $143,891 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 821) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
758 generic and 63 brand-name prescriptions · $143,891 in drug cost · 24 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Invega Sustenna | 27 | $85,221 | $3,156 |
| Aripiprazole | 38 | $2,090 | $55 |
| Gabapentin | 55 | $929 | $17 |
| Divalproex | 39 | $865 | $22 |
| Olanzapine | 51 | $707 | $14 |
See all 23 drugs
| Invega Sustenna | 27 | $85,221 | $3,156 |
| Aripiprazole | 38 | $2,090 | $55 |
| Gabapentin | 55 | $929 | $17 |
| Divalproex | 39 | $865 | $22 |
| Olanzapine | 51 | $707 | $14 |
| Dextroamphetamine-Amphetamine | 12 | $335 | $28 |
| Buspirone | 45 | $334 | $7 |
| Bupropion Xl | 15 | $308 | $21 |
| Hydroxyzine | 29 | $285 | $10 |
| Lorazepam | 40 | $249 | $6 |
| Lithium Carbonate | 46 | $234 | $5 |
| Quetiapine | 33 | $226 | $7 |
| Clonazepam | 57 | $150 | $3 |
| Trazodone | 46 | $114 | $2 |
| Prazosin | 14 | $110 | $8 |
| Duloxetine | 13 | $109 | $8 |
| Fluoxetine | 27 | $100 | $4 |
| Mirtazapine | 14 | $89 | $6 |
| Benztropine Mesylate | 15 | $64 | $4 |
| Risperidone | 12 | $61 | $5 |
| Escitalopram | 42 | $61 | $1 |
| Zolpidem | 14 | $24 | $2 |
| Sertraline | 25 | $21 | $1 |
Year by year
| 2024 | 821 | 55 | 0% (0) | 8% | $143,891 |
| 2023 | 675 | 70 | 0% (0) | 8% | $141,551 |
| 2022 | 783 | 61 | 0% (0) | 5% | $105,215 |
| 2021 | 614 | 55 | None | 2% | $27,210 |
| 2020 | 626 | 37 | 0% (0) | 4% | $29,627 |
| 2019 | 294 | 41 | 0% (0) | 5% | $29,129 |
| 2018 | 1,865 | 167 | None | 12% | $415,215 |
| 2017 | 1,222 | 120 | 0% (0) | 12% | $215,757 |
| 2015 | 20 | None | 0% (0) | None | $1,294 |
| 2014 | 43 | None | 0% (0) | None | $5,555 |
| 2013 | 522 | 35 | 0% (0) | 18% | $74,669 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 23 drugs
| Invega Sustenna | 18 | $60,805 | $3,378 |
| Abilify Maintena | 20 | $50,862 | $2,543 |
| Aripiprazole | 33 | $3,779 | $115 |
| Quetiapine | 41 | $1,351 | $33 |
| Buspirone | 40 | $926 | $23 |
| Hydroxyzine | 24 | $837 | $35 |
| Olanzapine Odt | 18 | $710 | $39 |
| Venlafaxine Hcl Er | 13 | $577 | $44 |
| Trazodone | 43 | $532 | $12 |
| Divalproex Sodium Er | 15 | $528 | $35 |
| Mirtazapine | 27 | $500 | $19 |
| Escitalopram | 41 | $419 | $10 |
| Sertraline | 40 | $415 | $10 |
| Lithium Carbonate | 35 | $403 | $12 |
| Risperidone | 13 | $386 | $30 |
| Gabapentin | 17 | $362 | $21 |
| Dextroamphetamine-Amphetamine | 12 | $362 | $30 |
| Lorazepam | 32 | $353 | $11 |
| Doxepin | 14 | $349 | $25 |
| Duloxetine | 15 | $317 | $21 |
| Fluoxetine | 17 | $291 | $17 |
| Clonazepam | 23 | $144 | $6 |
| Prazosin | 13 | $107 | $8 |
2022: 23 drugs
| Abilify Maintena | 11 | $29,802 | $2,709 |
| Aripiprazole | 45 | $8,231 | $183 |
| Olanzapine Odt | 18 | $3,464 | $192 |
| Quetiapine | 42 | $3,009 | $72 |
| Ziprasidone | 11 | $924 | $84 |
| Dextroamphetamine-Amphetamine | 20 | $759 | $38 |
| Sertraline | 43 | $622 | $14 |
| Bupropion Xl | 17 | $527 | $31 |
| Hydroxyzine | 18 | $501 | $28 |
| Clonazepam | 39 | $492 | $13 |
| Duloxetine | 21 | $422 | $20 |
| Lorazepam | 47 | $396 | $8 |
| Gabapentin | 15 | $389 | $26 |
| Clozapine | 50 | $377 | $8 |
| Divalproex | 20 | $348 | $17 |
| Buspirone | 20 | $310 | $16 |
| Lithium Carbonate | 36 | $308 | $9 |
| Mirtazapine | 32 | $298 | $9 |
| Benztropine Mesylate | 23 | $290 | $13 |
| Trazodone | 36 | $286 | $8 |
| Olanzapine | 20 | $249 | $12 |
| Escitalopram | 22 | $137 | $6 |
| Paroxetine | 13 | $90 | $7 |
2021: 20 drugs
| Duloxetine | 25 | $3,163 | $127 |
| Quetiapine | 48 | $1,447 | $30 |
| Trazodone | 56 | $774 | $14 |
| Prazosin | 18 | $771 | $43 |
| Olanzapine | 27 | $628 | $23 |
| Gabapentin | 21 | $606 | $29 |
| Clozapine | 18 | $503 | $28 |
| Venlafaxine Hcl Er | 21 | $481 | $23 |
| Clonazepam | 46 | $396 | $9 |
| Aripiprazole | 12 | $388 | $32 |
| Mirtazapine | 23 | $253 | $11 |
| Bupropion Xl | 12 | $246 | $20 |
| Lithium Carbonate | 28 | $246 | $9 |
| Lorazepam | 30 | $230 | $8 |
| Sertraline | 27 | $204 | $8 |
| Risperidone | 14 | $183 | $13 |
| Hydroxyzine | 13 | $174 | $13 |
| Metformin | 19 | $138 | $7 |
| Escitalopram | 15 | $111 | $7 |
| Paroxetine | 15 | $101 | $7 |
2020: 21 drugs
| Duloxetine | 36 | $4,429 | $123 |
| Aripiprazole | 24 | $2,252 | $94 |
| Prazosin | 31 | $1,072 | $35 |
| Gabapentin | 27 | $917 | $34 |
| Trazodone | 52 | $653 | $13 |
| Fluoxetine | 20 | $580 | $29 |
| Quetiapine | 40 | $554 | $14 |
| Clonazepam | 56 | $554 | $10 |
| Venlafaxine Hcl Er | 28 | $435 | $16 |
| Risperidone | 20 | $401 | $20 |
| Lithium Carbonate | 27 | $310 | $11 |
| Mirtazapine | 24 | $280 | $12 |
| Olanzapine | 12 | $262 | $22 |
| Sertraline | 35 | $225 | $6 |
| Bupropion Hcl Sr | 12 | $192 | $16 |
| Metformin | 27 | $172 | $6 |
| Temazepam | 12 | $133 | $11 |
| Escitalopram | 16 | $110 | $7 |
| Alprazolam | 13 | $94 | $7 |
| Lamotrigine | 12 | $82 | $7 |
| Lisinopril | 11 | $41 | $4 |
2019: 9 drugs
| Latuda | 13 | $23,438 | $1,803 |
| Quetiapine | 20 | $393 | $20 |
| Zolpidem Tartrate Er | 11 | $339 | $31 |
| Escitalopram | 25 | $312 | $12 |
| Clonazepam | 24 | $241 | $10 |
| Alprazolam | 16 | $194 | $12 |
| Lamotrigine | 11 | $146 | $13 |
| Trazodone | 13 | $101 | $8 |
| Sertraline | 11 | $70 | $6 |
2018: 40 drugs
| Invega Sustenna | 70 | $148,345 | $2,119 |
| Latuda | 43 | $68,463 | $1,592 |
| Abilify Maintena | 33 | $65,763 | $1,993 |
| Aripiprazole | 60 | $9,566 | $159 |
| Quetiapine Fumarate Er | 24 | $4,123 | $172 |
| Clozapine | 39 | $4,029 | $103 |
| Divalproex Sodium Er | 51 | $3,744 | $73 |
| Olanzapine Odt | 15 | $2,823 | $188 |
| Haloperidol Decanoate | 24 | $2,716 | $113 |
| Quetiapine | 102 | $2,380 | $23 |
| Ziprasidone | 29 | $2,271 | $78 |
| Prazosin | 51 | $1,622 | $32 |
| Bupropion Xl | 36 | $1,312 | $36 |
| Trazodone | 104 | $1,296 | $12 |
| Duloxetine | 45 | $1,283 | $29 |
| Olanzapine | 63 | $1,211 | $19 |
| Benztropine Mesylate | 96 | $1,022 | $11 |
| Risperidone | 80 | $995 | $12 |
| Haloperidol | 29 | $867 | $30 |
| Naltrexone | 20 | $780 | $39 |
| Fluoxetine | 68 | $774 | $11 |
| Gabapentin | 44 | $696 | $16 |
| Buspirone | 41 | $657 | $16 |
| Mirtazapine | 60 | $607 | $10 |
| Divalproex | 20 | $545 | $27 |
| Venlafaxine Hcl Er | 45 | $518 | $12 |
| Topiramate | 44 | $433 | $10 |
| Propranolol | 28 | $426 | $15 |
| Bupropion Hcl Sr | 20 | $343 | $17 |
| Hydroxyzine Pamoate | 22 | $316 | $14 |
| Clonazepam | 63 | $313 | $5 |
| Sertraline | 51 | $274 | $5 |
| Lithium Carbonate | 27 | $244 | $9 |
| Lamotrigine | 24 | $209 | $9 |
| Paroxetine | 18 | $204 | $11 |
| Bupropion | 12 | $175 | $15 |
| Lorazepam | 35 | $166 | $5 |
| Escitalopram | 11 | $130 | $12 |
| Zolpidem | 16 | $98 | $6 |
| Citalopram Hbr | 18 | $78 | $4 |
2017: 34 drugs
| Invega Sustenna | 35 | $71,539 | $2,044 |
| Latuda | 21 | $29,380 | $1,399 |
| Paliperidone Er | 11 | $10,543 | $958 |
| Aripiprazole | 33 | $4,337 | $131 |
| Divalproex Sodium Er | 20 | $3,019 | $151 |
| Quetiapine Fumarate Er | 17 | $2,226 | $131 |
| Quetiapine | 81 | $1,842 | $23 |
| Bupropion Xl | 31 | $1,338 | $43 |
| Olanzapine | 59 | $1,138 | $19 |
| Haloperidol | 25 | $945 | $38 |
| Mirtazapine | 32 | $834 | $26 |
| Trazodone | 72 | $782 | $11 |
| Buspirone | 23 | $767 | $33 |
| Divalproex | 31 | $740 | $24 |
| Naltrexone | 13 | $673 | $52 |
| Gabapentin | 34 | $631 | $19 |
| Prazosin | 21 | $587 | $28 |
| Duloxetine | 20 | $542 | $27 |
| Fluoxetine | 61 | $475 | $8 |
| Bupropion Hcl Sr | 25 | $419 | $17 |
| Clonazepam | 70 | $353 | $5 |
| Topiramate | 37 | $349 | $9 |
| Benztropine Mesylate | 30 | $323 | $11 |
| Risperidone | 35 | $262 | $7 |
| Paroxetine | 22 | $245 | $11 |
| Venlafaxine Hcl Er | 27 | $236 | $9 |
| Lithium Carbonate | 30 | $208 | $7 |
| Lithium Carbonate Er | 11 | $208 | $19 |
| Propranolol | 17 | $161 | $9 |
| Hydroxyzine Pamoate | 15 | $147 | $10 |
| Lorazepam | 17 | $100 | $6 |
| Sertraline | 18 | $87 | $5 |
| Lamotrigine | 15 | $77 | $5 |
| Citalopram Hbr | 12 | $73 | $6 |
2013: 21 drugs
| Invega Sustenna | 19 | $22,849 | $1,203 |
| Abilify | 18 | $19,028 | $1,057 |
| Olanzapine | 44 | $8,877 | $202 |
| Ziprasidone | 14 | $3,994 | $285 |
| Quetiapine | 16 | $3,959 | $247 |
| Strattera | 12 | $3,121 | $260 |
| Cymbalta | 13 | $2,724 | $210 |
| Divalproex Sodium Er | 34 | $1,842 | $54 |
| Risperidone | 33 | $896 | $27 |
| Lamotrigine | 15 | $489 | $33 |
| Gabapentin | 17 | $465 | $27 |
| Trazodone | 37 | $283 | $8 |
| Topiramate | 12 | $240 | $20 |
| Alprazolam | 25 | $232 | $9 |
| Fluoxetine | 13 | $171 | $13 |
| Mirtazapine | 16 | $168 | $11 |
| Amitriptyline | 33 | $158 | $5 |
| Zolpidem | 27 | $158 | $6 |
| Sertraline | 16 | $109 | $7 |
| Lorazepam | 13 | $104 | $8 |
| Citalopram Hbr | 13 | $70 | $5 |
Money from drug and device companies
$225 in 2024
| 2024 | 7 | 10 | None | $225 |
| 2023 | 4 | 18 | None | $540 |
| 2022 | 2 | 3 | None | $270 |
| 2021 | 1 | 1 | None | $23 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alkermes | Aristada | $77 | 4 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $43 | 1 payment
|
| Indivior | Perseris | $27 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Cobenfy | $24 | 1 payment
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $20 | 1 payment
|
| Supernus Pharmaceuticals | Qelbree | $18 | 1 payment
|
See all 10 published payments
| E.R. Squibb & Sons L.L.C. | Meals · 2024-11-22 | Cobenfy | $24 |
| Alkermes | Meals · 2024-11-21 | Aristada | $27 |
| Alkermes | Meals · 2024-09-30 | Aristada | $15 |
| Janssen Pharmaceuticals | Meals · 2024-06-13 | Invega Sustenna | $43 |
| Alkermes | Meals · 2024-02-20 | Aristada | $17 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2024-02-19 | Caplyta | $20 |
| Indivior | Meals · 2024-02-16 | Perseris | $27 |
| Otsuka America Pharmaceutical | Meals · 2024-02-15 | Abilify Maintena | $16 |
| Supernus Pharmaceuticals | Meals · 2024-02-13 | Qelbree | $18 |
| Alkermes | Meals · 2024-02-12 | Aristada | $18 |
See earlier years (2023, 2022, 2021)
2023: $540
| Janssen Pharmaceuticals | Invega Sustenna | $359 | 6 payments
|
| Alkermes | Aristada | $150 | 10 payments
|
| Lundbeck | Abilify Asimtufii | $16 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $16 | 1 payment
|
2022: $270
| Janssen Pharmaceuticals | Invega Sustenna | $250 | 2 payments
|
| Alkermes | Aristada | $20 | 1 payment
|
2021: $23
| Janssen Pharmaceuticals | Invega Sustenna | $23 | 1 payment
|
Professional record
- NPI
- 1588864821
- Licence
- CA G50533California G50533: Current · expires 2027-05-31
- Trained
- Stanford University School of Medicine, 1981
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Psychiatry (2084P0800X); Federal specialty code 2084F0202X (2084F0202X)
- Mailing address
- 1860 Mowry Ave Ste 400, Fremont, CA, 94538
- NPI first listed
- 2007-07-24
- NPI last updated
- 2024-10-01
- NPI record certified
- 2024-10-01
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 12004 Valpredo Rd, Bakersfield, CA, 93313